This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Pfizer Past Earnings Performance
Past criteria checks 6/6
Key information
11.1%
Earnings growth rate
12.8%
EPS growth rate
Pharmaceuticals Industry Growth | 30.5% |
Revenue growth rate | 16.3% |
Return on equity | 32.7% |
Net Margin | 31.3% |
Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Pfizer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 100,330 | 31,366 | 12,200 | 11,428 |
02 Oct 22 | 99,878 | 29,953 | 11,327 | 11,417 |
03 Jul 22 | 101,275 | 29,481 | 10,038 | 11,400 |
03 Apr 22 | 92,433 | 25,410 | 9,404 | 10,824 |
31 Dec 21 | 81,288 | 22,413 | 9,562 | 10,360 |
03 Oct 21 | 68,877 | 19,485 | 9,714 | 9,972 |
04 Jul 21 | 55,119 | 12,236 | 11,676 | 9,589 |
04 Apr 21 | 46,084 | 9,032 | 11,454 | 9,184 |
31 Dec 20 | 41,651 | 6,630 | 11,418 | 8,709 |
27 Sep 20 | 32,334 | 212 | 11,006 | 8,084 |
28 Jun 20 | 34,737 | 6,977 | 10,565 | 7,727 |
29 Mar 20 | 38,137 | 9,427 | 11,637 | 7,716 |
31 Dec 19 | 40,905 | 10,707 | 12,766 | 7,721 |
29 Sep 19 | 53,039 | 16,211 | 13,755 | 7,891 |
30 Jun 19 | 53,656 | 12,638 | 14,050 | 7,948 |
31 Mar 19 | 53,859 | 11,464 | 14,004 | 7,914 |
31 Dec 18 | 40,825 | 3,824 | 12,149 | 7,713 |
30 Sep 18 | 53,373 | 23,808 | 14,481 | 7,827 |
01 Jul 18 | 53,244 | 22,545 | 14,492 | 7,686 |
01 Apr 18 | 52,673 | 21,746 | 14,509 | 7,673 |
31 Dec 17 | 52,546 | 21,305 | 14,606 | 7,645 |
01 Oct 17 | 52,471 | 9,791 | 14,546 | 7,843 |
02 Jul 17 | 52,347 | 8,308 | 14,608 | 7,861 |
02 Apr 17 | 52,598 | 7,281 | 14,959 | 7,826 |
31 Dec 16 | 52,824 | 7,198 | 14,894 | 7,858 |
02 Oct 16 | 53,243 | 6,270 | 14,956 | 7,652 |
03 Jul 16 | 52,286 | 7,036 | 14,697 | 7,797 |
03 Apr 16 | 50,992 | 7,615 | 14,339 | 7,787 |
Quality Earnings: PFE has high quality earnings.
Growing Profit Margin: PFE's current net profit margins (31.3%) are higher than last year (27.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PFE's earnings have grown by 11.1% per year over the past 5 years.
Accelerating Growth: PFE's earnings growth over the past year (39.9%) exceeds its 5-year average (11.1% per year).
Earnings vs Industry: PFE earnings growth over the past year (39.9%) exceeded the Pharmaceuticals industry 21.1%.
Return on Equity
High ROE: PFE's Return on Equity (32.7%) is considered high.